Close Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

Longmen Capital

Investor type Private Equity Firm


Unlock datapoints

Portfolio analytics



News & Media

Add fund to favorites
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.
Total investments 11
Average round size
The average size of a deal this fund participated in
Portfolio companies 11
Rounds per year 2.20
Lead investments 1
Key employees Soon

Areas of investment

  • Health Care
  • Biotechnology
  • Pharmaceutical
  • Biopharma
  • Medical

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of Longmen Capital:
Typical Co-investors
Longmen Capital is more likely to invest in rounds together with the following funds:
There are no funds here. If we find new data, we will add it here.
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after Longmen Capital:
There are no funds here. If we find new data, we will add it here.

Look at other 50 related and similar funds Collapse list
Fund NameLocation
Aoyou Group -
Chess Ventures California, San Francisco, United States
Edson Student Entrepreneur Initiative Arizona, Scottsdale, United States
GS Shop Seoul, Seoul-t'ukpyolsi, South Korea
Kaigen Pharma Japan, Osaka, Osaka Prefecture
Longmaster China, Guiyang, Guizhou
Next Fifteen Communications Group England, London, United Kingdom
PTB Ventures New York, New York, United States
Zhongsheng Jinrong -

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

Kaidi Medical

$15M10 Mar 2022 Nanjing, Jiangsu, China

Crystal Egg Bio

Health Care
07 Jan 2022 Shenzhen, Guangdong, China

Qiyu Biotech

Health Care
$30M23 Dec 2021 Shanghai, China

Hopstem Biotech

Health Care
27 May 2021 Shangcheng District, Zhejiang, China

Chinagene Tech

Clinical Trials
$10M29 Mar 2021 Changping District, Beijing, China

Health Care
$10M23 Feb 2021 Shanghai, China

Ractigen Therapeutics

Health Care
$17M18 Feb 2021 Nantong, Jiangsu, China

Prosit Sole Biotechnology

07 Feb 2021 Haidian, Beijing, China


Drug Discovery
Medical Device
$105M23 Oct 2020 Maryland, United States


  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Longmen Capital?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!

You can raise money with us faster

Get matched with relevant funds

Find decision makers data

Connect with investors by email

Remind me later
...and save more than 200 hours*
*-Our recommendation and outreach system saves up to 200 hours of founder time on fundraising for seed and series A+ startups
We use LinkedIn only to verify your account. We don't import or message your contacts, nor post on your behalf.
By creating an account, you agree to our Terms of Service and Privacy Policy.
Crunchbase icon

Content report

The following text will be sent to our editors: